Zobrazeno 1 - 10
of 33
pro vyhledávání: ''
Autor:
Khoa D. Nguyen, Grace H. Jean, Claus U. Niemann, Katherine J. L. Jackson, Tho D. Pham, Ramona A. Hoh, Emily Haraguchi, Katharina Röltgen, Julie Parsonnet, Yi Liu, Sandra C. A. Nielsen, Fan Yang, Kari C. Nadeau, Ji-Yeun Lee, Scott D. Boyd, Krishna M. Roskin, Robert S. Ohgami, Eleanor M. Osborne, Oliver F. Wirz
Publikováno v:
Science (New York, N.y.)
Kids armed with anti-coronavirus B cells It remains unclear whether B cell repertoires against coronaviruses and other pathogens differ between adults and children and how important these distinctions are. Yang et al. analyzed blood samples from youn
Autor:
Dhira Joshi, Lucy R. Marshall, Lucy R. Wedderburn, Stavroula Paraskevopoulou, Steve Gamblin, Georgina H. Cornish, Sonia Gandhi, Charles Swanton, John W. McCauley, William Bolland, Svend Kjaer, Nikhil Faulkner, Hannah Rickman, Rachel Ulferts, Philip Hobson, D.J. Benton, Laura E. McCoy, Ana Agua-Doce, Rupert Beale, Annachiara Rosa, Chloe Roustan, Nicola O’Reilly, Catherine F Houlihan, Christopher Earl, Eleni Nastouli, A.G. Wrobel, Rachael Thompson, Brigitta Stockinger, Kirsty Thomson, Catherine Moore, Bethany R. Jebson, Anna Radziszewska, Coziana Ciurtin, Andrew Riddell, Saira Hussain, Emilie Sanchez, Peter Cherepanov, Elizabeth C. Rosser, Meredyth G. Ll Wilkinson, Kevin W. Ng, Ruth Harvey, Philip A. Walker, Hannah Peckham, Judith Heaney, Gee Yen Shin, Moira J. Spyer, George Kassiotis
Publikováno v:
Science (New York, N.y.)
Science
Science
Antibodies predating infection Immunological memory after infection with seasonal human coronaviruses (hCoVs) may potentially contribute to cross-protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Ng et al. report that i
Autor:
Paul B. Harvilla, Ninkka Tamot, Adam Zwolak, Jason Ho, Matthew D. Truppo, Rajitha Doddareddy, Tong-Yuan Yang, M. Jack Borrok, Ian White, Chowdhury Partha, Qun Jiao, Rajkumar Ganesan, Brian Geist
Publikováno v:
mAbs
article-version (VoR) Version of Record
article-version (VoR) Version of Record
The global health crisis and economic tolls of COVID-19 necessitate a panoply of strategies to treat SARS-CoV-2 infection. To date, few treatment options exist, although neutralizing antibodies against the spike glycoprotein have proven to be effecti
Autor:
Emily S.J. Edwards, P. Mark Hogarth, Stephanie Stojanovic, Heidi E. Drummer, Nirupama Varese, James H McMahon, Robyn E O'Hehir, Anton Y. Peleg, Irene Boo, Menno C. van Zelm, Pei M. Aui, Gemma E. Hartley
Publikováno v:
Science Immunology
Memory B cells specific for SARS-CoV-2 spike and nucleocapsid proteins persist in peripheral blood after recovery from COVID-19.
Lasting immunity following SARS-CoV-2 infection is questioned because serum antibodies decline in convalescence. How
Lasting immunity following SARS-CoV-2 infection is questioned because serum antibodies decline in convalescence. How
Autor:
Michel C. Nussenzweig, Jennifer R. Keeffe, Christopher O. Barnes, Yu E. Lee, Pauline R. Hoffman, Susan Ou, Hung-Jen Wu, Alexander A. Cohen, Leesa M. Kakutani, Anthony P. West, Pamela J. Bjorkman, Mark Howarth, Priyanthi N. P. Gnanapragasam
Publikováno v:
Science
Science, 371(6530):735-741
Science (New York, N.y.)
bioRxiv
article-version (status) pre
article-version (number) 1
Science, 371(6530):735-741
Science (New York, N.y.)
bioRxiv
article-version (status) pre
article-version (number) 1
Fighting zoonotic coronaviruses In the past 20 years, three betacoronaviruses thought to have originated in bats have caused devastating disease in humans. The global pandemic caused by the latest such virus, severe acute respiratory syndrome coronav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46309a536c6a32339ee8494c4bc7b752
https://doi.org/10.1101/2020.11.17.387092
https://doi.org/10.1101/2020.11.17.387092
Autor:
Timothy M. Caradonna, Edward T. Ryan, A. John Iafrate, Rachel Mills, Mohammad Kamruzzaman, Tyler E. Miller, Galit Alter, Damien Slater, Caroline Atyeo, Ariana Nodoushani, Zhenfeng Li, Andrew S. Azman, Stephen B. Calderwood, Forrest K. Jones, Blake M. Hauser, Anita S. Iyer, Erica Teng, Regina C. LaRocque, Jason B. Harris, Elizabeth Oliver, Guillaume Mellon, Stephanie Fischinger, Meagan Kelly, Wilfredo F. Garcia-Beltran, John A. Branda, Richelle C. Charles, Jingyou Yu, Michael G Astudillo, Aaron G. Schmidt, Diane Yang, Stephen A. Lauer, Margaret Becker, Sarah E Turbett, Dan H. Barouch, Jared Feldman
Publikováno v:
Science Immunology
IgM and IgA responses to SARS-CoV-2 RBD in severe COVID patients decay rapidly, while IgG responses persist for over 3 months.
We measured plasma and/or serum antibody responses to the receptor-binding domain (RBD) of the spike (S) protein of SA
We measured plasma and/or serum antibody responses to the receptor-binding domain (RBD) of the spike (S) protein of SA
Autor:
Hui Cai, Ann-Kathrin Wallisch, Wei Chen, Ugur Sahin, Ritu Sarkar, Kena A. Swanson, Daniel Maurus, Alexander Muik, Özlem Türeci, Philip R. Dormitzer, Bianca Sänger, Julia Mühl
Publikováno v:
Science (New York, N.y.)
Science
Science
Vaccine protects against B1.1.7 variant The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B1.1.7 (VOC 202012/01) variant that emerged in late 2020 in the United Kingdom has many changes in the spike protein gene. Three of these are ass
Autor:
Emily C. Woodford, Scott E. Hensley, Rita Leite, Divij Mathew, Sigrid Gouma, Justin Kim, Marcus J. Bolton, Ajinkya Pattekar, Anurag Verma, Miren B. Dhudasia, Michal A. Elovitz, Madison E. Weirick, Dustin D. Flannery, JoEllen Weaver, Nicholas Han, Amy E. Baxter, Claudia P. Arevalo, Jeanette Dougherty, Madeline R. Pfeifer, Daniel J. Rader, Eileen C. Goodwin, Allison R. Greenplate, Elizabeth M. Anderson, Jeffrey S. Morris, E. John Wherry, Karen M. Puopolo, Laura A. Vella, Sagori Mukhopadhyay, Oliva Kuthuru, Jeffrey S. Gerber
Publikováno v:
Science Immunology
medRxiv
article-version (status) pre
article-version (number) 1
medRxiv
article-version (status) pre
article-version (number) 1
Limited data are available for pregnant women affected by SARS-CoV-2. Serological tests are critically important to determine exposure and immunity to SARS-CoV-2 within both individuals and populations. We completed SARS-CoV-2 serological testing of
Autor:
Shufeng Liu, Gabrielle Grubbs, Laura Klenow, Supriya Ravichandran, Elizabeth M. Coyle, Hana Golding, Surender Khurana, Tony T. Wang, Juanjie Tang
Publikováno v:
Science Translational Medicine
Understanding antibody epitope diversity and affinity generated by SARS-CoV-2 spike antigens in rabbits can aid COVID-19 vaccine development.
Multiple vaccine candidates against SARS-CoV-2 based on viral spike protein are under development. Howe
Multiple vaccine candidates against SARS-CoV-2 based on viral spike protein are under development. Howe
Autor:
Laura M. Walker, Mrunal Sakharkar, Ching-Lin Hsieh, Kartik Chandran, Ethan Laudermilch, Ariel S. Wirchnianski, Barney S. Graham, Daniel P. Maurer, Deli Huang, Sarat Pudi, John M. Dye, Elizabeth Champney, Asparouh Lilov, James E. Voss, David Nemazee, Melanie Sinclair, Catalina Florez, Denise Haslwanter, Jason S. McLellan, M. Eugenia Dieterle, Dennis R. Burton, Andrew S. Herbert, Ralph S. Baric, Irina Burnina, Nicole V. Johnson, Anna Z. Wec, Longping V. Tse, Daniel Wrapp, Rohit K. Jangra, Nianshuang Wang, Cecilia M. O’Brien, Shu Lin, Juergen Hermann Nett, J. Maximilian Fels, Carl Hirschie Johnson, Michael G. Brown, Robert H. Bortz
Publikováno v:
Science (New York, N.y.)
Science
Science
Seeking broad protection As scientists develop therapeutic antibodies and vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the risk of emergent coronaviruses makes it important to also identify broadly protective antibod